The allergic effector unit: From basic science to drug-targetable mast cell–eosinophil interactions in patients

Pier Giorgio Puzzovio; Francesca Levi-Schaffer

doi:10.1016/j.jaip.2021.07.008

The allergic effector unit: From basic science to drug-targetable mast cell–eosinophil interactions in patients

Pier Giorgio Puzzovio, Francesca Levi-Schaffer^*

^*Corresponding author for this work

School of Pharmacy

Research output: Contribution to journal › Letter › peer-review

4 Scopus citations

Original language	English
Pages (from-to)	3845-3846
Number of pages	2
Journal	Journal of Allergy and Clinical Immunology: In Practice
Volume	9
Issue number	10
DOIs	https://doi.org/10.1016/j.jaip.2021.07.008
State	Published - Oct 2021

Bibliographical note

Funding Information:
This study was funded by Rosetrees Trust (UK), Aimwell Charitable Trust (UK), Israel Science Foundation (Grant no. 442/18), Israel Ministry of Science & Technology, and Emalie Gutterman Memorial Endowed Fund for COPD Related Research (USA). F. Levi-Schaffer is affiliated with the Adolph and Klara Brettler Center for Molecular Pharmacology and Therapeutics at the School of Pharmacy of the Hebrew University of Jerusalem.

Funding Information:
This study was funded by Rosetrees Trust (UK), Aimwell Charitable Trust (UK), Israel Science Foundation (Grant no. 442/18), Israel Ministry of Science & Technology, and Emalie Gutterman Memorial Endowed Fund for COPD Related Research (USA). F. Levi-Schaffer is affiliated with the Adolph and Klara Brettler Center for Molecular Pharmacology and Therapeutics at the School of Pharmacy of the Hebrew University of Jerusalem.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.jaip.2021.07.008

Cite this

@article{b1a718bcb5af47d38d030b6770b47449,

title = "The allergic effector unit: From basic science to drug-targetable mast cell–eosinophil interactions in patients",

author = "Puzzovio, \{Pier Giorgio\} and Francesca Levi-Schaffer",

note = "Funding Information: This study was funded by Rosetrees Trust (UK), Aimwell Charitable Trust (UK), Israel Science Foundation (Grant no. 442/18), Israel Ministry of Science \& Technology, and Emalie Gutterman Memorial Endowed Fund for COPD Related Research (USA). F. Levi-Schaffer is affiliated with the Adolph and Klara Brettler Center for Molecular Pharmacology and Therapeutics at the School of Pharmacy of the Hebrew University of Jerusalem. Funding Information: This study was funded by Rosetrees Trust (UK), Aimwell Charitable Trust (UK), Israel Science Foundation (Grant no. 442/18), Israel Ministry of Science \& Technology, and Emalie Gutterman Memorial Endowed Fund for COPD Related Research (USA). F. Levi-Schaffer is affiliated with the Adolph and Klara Brettler Center for Molecular Pharmacology and Therapeutics at the School of Pharmacy of the Hebrew University of Jerusalem.",

year = "2021",

month = oct,

doi = "10.1016/j.jaip.2021.07.008",

language = "אנגלית",

volume = "9",

pages = "3845--3846",

journal = "Journal of Allergy and Clinical Immunology: In Practice",

issn = "2213-2198",

publisher = "American Academy of Allergy, Asthma and Immunology",

number = "10",

}

TY - JOUR

T1 - The allergic effector unit

T2 - From basic science to drug-targetable mast cell–eosinophil interactions in patients

AU - Puzzovio, Pier Giorgio

AU - Levi-Schaffer, Francesca

N1 - Funding Information: This study was funded by Rosetrees Trust (UK), Aimwell Charitable Trust (UK), Israel Science Foundation (Grant no. 442/18), Israel Ministry of Science & Technology, and Emalie Gutterman Memorial Endowed Fund for COPD Related Research (USA). F. Levi-Schaffer is affiliated with the Adolph and Klara Brettler Center for Molecular Pharmacology and Therapeutics at the School of Pharmacy of the Hebrew University of Jerusalem. Funding Information: This study was funded by Rosetrees Trust (UK), Aimwell Charitable Trust (UK), Israel Science Foundation (Grant no. 442/18), Israel Ministry of Science & Technology, and Emalie Gutterman Memorial Endowed Fund for COPD Related Research (USA). F. Levi-Schaffer is affiliated with the Adolph and Klara Brettler Center for Molecular Pharmacology and Therapeutics at the School of Pharmacy of the Hebrew University of Jerusalem.

PY - 2021/10

Y1 - 2021/10

UR - https://www.scopus.com/pages/publications/85115930745

U2 - 10.1016/j.jaip.2021.07.008

DO - 10.1016/j.jaip.2021.07.008

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.letter???

C2 - 34627540

AN - SCOPUS:85115930745

SN - 2213-2198

VL - 9

SP - 3845

EP - 3846

JO - Journal of Allergy and Clinical Immunology: In Practice

JF - Journal of Allergy and Clinical Immunology: In Practice

IS - 10

ER -

The allergic effector unit: From basic science to drug-targetable mast cell–eosinophil interactions in patients

Bibliographical note

UN SDGs

Access to Document

Other files and links

Cite this